De Francesco Francesco, Marchesini Andrea, Riccio Michele
Department of Reconstructive Surgery and Hand Surgery, Azienda Ospedaliera Universitaria Delle Marche, 60126 Ancona, Italy.
J Clin Med. 2025 Jun 6;14(12):4024. doi: 10.3390/jcm14124024.
: Atrophic nonunion presents a significant challenge in hand surgery, often resulting in chronic pain and functional disability. Traditional surgical treatments such as bone grafting and internal fixation may be insufficient. This study evaluates the feasibility, safety, and preliminary effectiveness of a regenerative-first surgical protocol that combines autologous bone micro-grafts with a fresh human amniotic membrane to create a biologically active regenerative chamber. : A total of 8 patients (6 males, 2 females; age range: 22-56 years) with an atrophic nonunion of metacarpals and phalanges were treated using a regenerative-first surgical approach. Autologous bone was harvested from the iliac crest and mechanically disaggregated via Rigenera technology to obtain micro-grafts enriched with osteoprogenitor cells and extracellular matrix fragments. These were applied to the bone defect and wrapped in a fresh amniotic membrane, creating a biologically active chamber. Fixation was achieved using low-profile plates or screws, and all patients underwent early protected mobilization. : Radiographic consolidation was achieved in all patients within 2 months postoperatively. Functional outcomes at final follow-up demonstrated excellent or good results in Total Active Motion (TAM), with grip and pinch strength within normative ranges and minimal residual pain. : This preliminary series suggests that combining autologous bone micro-grafts with an amniotic membrane in a regenerative surgical protocol is a promising strategy for managing atrophic nonunion in the hand. The approach was associated with rapid consolidation and excellent functional recovery. Further research with larger, controlled cohorts is warranted to validate efficacy and define standardized indications and techniques.
萎缩性骨不连在手外科中是一个重大挑战,常导致慢性疼痛和功能障碍。传统的外科治疗方法,如骨移植和内固定,可能并不充分。本研究评估了一种以再生为先的手术方案的可行性、安全性和初步有效性,该方案将自体骨微移植与新鲜人羊膜相结合,以创建一个具有生物活性的再生腔。
共有8例(6例男性,2例女性;年龄范围:22 - 56岁)掌骨和指骨萎缩性骨不连患者采用了以再生为先的手术方法进行治疗。从髂嵴采集自体骨,并通过Rigenera技术进行机械分解,以获得富含骨祖细胞和细胞外基质片段的微移植体。将这些微移植体应用于骨缺损处,并用新鲜羊膜包裹,形成一个具有生物活性的腔室。使用小型钢板或螺钉进行固定,所有患者均接受早期保护性活动。
所有患者在术后2个月内均实现了影像学骨愈合。末次随访时的功能结果显示,总主动活动度(TAM)结果优异或良好,握力和捏力在正常范围内,残余疼痛极小。
这个初步系列研究表明,在再生手术方案中将自体骨微移植与羊膜相结合是治疗手部萎缩性骨不连的一种有前景的策略。该方法与快速骨愈合和优异的功能恢复相关。需要进一步开展更大规模的对照队列研究来验证疗效,并确定标准化的适应症和技术。